Desferrioxamine X2

Details

Top
Internal ID 6013b046-7d9c-47f9-891a-66bb68a5f0ea
Taxonomy Phenylpropanoids and polyketides > Macrolactams
IUPAC Name 1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclotriacontane-2,5,12,15,22,25-hexone
SMILES (Canonical) C1CCN(C(=O)CCC(=O)NCCCCN(C(=O)CCC(=O)NCCCCN(C(=O)CCC(=O)NC1)O)O)O
SMILES (Isomeric) C1CCN(C(=O)CCC(=O)NCCCCN(C(=O)CCC(=O)NCCCCN(C(=O)CCC(=O)NC1)O)O)O
InChI InChI=1S/C24H42N6O9/c31-19-7-10-23(35)29(38)17-5-2-15-27-21(33)9-12-24(36)30(39)18-6-3-14-26-20(32)8-11-22(34)28(37)16-4-1-13-25-19/h37-39H,1-18H2,(H,25,31)(H,26,32)(H,27,33)
InChI Key DDJODPOFWJITNU-UHFFFAOYSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C24H42N6O9
Molecular Weight 558.60 g/mol
Exact Mass 558.30132694 g/mol
Topological Polar Surface Area (TPSA) 209.00 Ų
XlogP -3.30
Atomic LogP (AlogP) -0.32
H-Bond Acceptor 9
H-Bond Donor 6
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Desferrioxamine X2

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.5000 50.00%
Caco-2 - 0.8458 84.58%
Blood Brain Barrier + 0.7250 72.50%
Human oral bioavailability + 0.7571 75.71%
Subcellular localzation Mitochondria 0.7099 70.99%
OATP2B1 inhibitior - 0.7161 71.61%
OATP1B1 inhibitior + 0.9684 96.84%
OATP1B3 inhibitior + 0.9391 93.91%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.5860 58.60%
P-glycoprotein inhibitior - 0.4453 44.53%
P-glycoprotein substrate - 0.9371 93.71%
CYP3A4 substrate - 0.6497 64.97%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8321 83.21%
CYP3A4 inhibition - 0.8674 86.74%
CYP2C9 inhibition - 0.8768 87.68%
CYP2C19 inhibition - 0.8802 88.02%
CYP2D6 inhibition - 0.9240 92.40%
CYP1A2 inhibition - 0.8860 88.60%
CYP2C8 inhibition - 0.9950 99.50%
CYP inhibitory promiscuity - 0.9947 99.47%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.7200 72.00%
Carcinogenicity (trinary) Non-required 0.4593 45.93%
Eye corrosion - 0.9753 97.53%
Eye irritation - 0.7415 74.15%
Skin irritation - 0.7432 74.32%
Skin corrosion - 0.9228 92.28%
Ames mutagenesis - 0.6778 67.78%
Human Ether-a-go-go-Related Gene inhibition - 0.4152 41.52%
Micronuclear + 0.7100 71.00%
Hepatotoxicity + 0.7500 75.00%
skin sensitisation - 0.8790 87.90%
Respiratory toxicity - 0.6556 65.56%
Reproductive toxicity + 0.5667 56.67%
Mitochondrial toxicity + 0.7125 71.25%
Nephrotoxicity - 0.6718 67.18%
Acute Oral Toxicity (c) III 0.5941 59.41%
Estrogen receptor binding + 0.6892 68.92%
Androgen receptor binding - 0.5312 53.12%
Thyroid receptor binding + 0.5616 56.16%
Glucocorticoid receptor binding - 0.5248 52.48%
Aromatase binding - 0.5348 53.48%
PPAR gamma + 0.6396 63.96%
Honey bee toxicity - 0.9634 96.34%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity - 0.8300 83.00%
Fish aquatic toxicity - 0.8923 89.23%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 91.12% 98.95%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 88.91% 96.09%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 86.94% 85.14%
CHEMBL5103 Q969S8 Histone deacetylase 10 84.45% 90.08%
CHEMBL3310 Q96DB2 Histone deacetylase 11 83.57% 88.56%
CHEMBL4208 P20618 Proteasome component C5 83.02% 90.00%
CHEMBL4040 P28482 MAP kinase ERK2 82.54% 83.82%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 82.16% 95.56%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 81.95% 93.40%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 80.65% 93.03%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 14671618
LOTUS LTS0189094
wikiData Q75062670